Skip to content

The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person

Lung Cancer | Lymphoma | Breast Cancer | Gynecologic Cancer | Gastro-intestinal Cancer | Genito-Urinary Cancer

Phase 2 randomized controlled study using a waitlist control group. The study also has a single arm pre-post test 12-week chair-based exercise arm for those who have received the geriatric assessment in the older adults with cancer clinic (geriatric oncology clinic).

Study Duration 2.5 years

Study Agent/ Intervention/ Procedure Comprehensive Geriatric Assessment and Management (GAM) combined with online chair-based exercise (CBE) and health education for 12 weeks.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    65 and up

Participation Criteria

Inclusion Criteria:

1. Aged 65+ years.
2. Diagnosed with lung, gastrointestinal (GI) , breast, Gynecologic or Genitourinary (GU) cancer or lymphoma who are referred for chemotherapy or immunotherapy and have not received \> 4 weeks of systemic treatment.

4) Have a physician estimated life expectancy of \>6 months. 5) Be physically inactive (no more than 90 min moderate to vigorous activity per week as per GLTEQ and do not currently meet the recommended physical activity volume of 90 min of aerobic exercise/week).

6) Able to speak and understand English. 7) Able to give informed consent. 8) Are considered safe to participate in the weekly classes as per their treating oncologist.

Eligible support persons are:

1. Identified by the older adult as their support person.
2. Aged 18 years and over.
3. Able to speak and understand English.
4. Able to give informed consent.

Exclusion Criteria:

1. Severe neuropsychiatric abnormalities (e.g., moderate-severe dementia) per the treating physician; and
2. Clinic visit with a geriatrician in the previous 12 months (they have already received part of the intervention).
3. Chest tube in-situ.

Exclusion criteria support person:

Not able to give informed consent.

Study Location

Sunybrook Health Sciences Centre, Odette Cancer Centre
Sunybrook Health Sciences Centre, Odette Cancer Centre
Toronto, Ontario
Canada

Contact Study Team

Backup Contact

Ines Menjak, MD

[email protected]
416-480-6100
Primary Contact

Urban Emmenegger, MD

[email protected]
416-480-6100
Princess Margaret Cancer Centre
Princess Margaret Cancer Centre
Toronto, Ontario
Canada

Contact Study Team

Primary Contact

Shabbir Alibhai

[email protected]
Study Sponsored By
University of Toronto
Participants Required
More Information
Study ID: NCT05509751